Teri Willey
P2C Managing Director & Officer at Pathway to Cures
About
Founder and managing director who launched and leads Pathway to Cures since November 2022. Brings over 35 years of experience commercializing early-stage research and launching science-based venture funds, including founding managing director roles at IU Ventures and ARCH development partners.
Colleagues at Pathway to Cures
Amy L. Dunn
Chair, Medical and Scientific Advisory Council (MASAC) for NBDF at Pathway to Cures
Beth Whitehouse
NBDF Senior Vice President for Advancement at Pathway to Cures
Gilbert C. White
P2C Board Vice Chair & Secretary at Pathway to Cures
Glenn Pierce
Scientific Advisory Group Co-Chair at Pathway to Cures
Haiyan Jiang
Scientific Advisory Group Member at Pathway to Cures
Katherine High
Scientific Advisory Group Member at Pathway to Cures
Leonard Valentino
P2C Entrepreneur in Residence and CEO at Pathway to Cures
Michael Recht
Chair, P2C Scientific Advisory Group and Chief Medical and Scientific Advisor at Pathway to Cures